BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pachman LM, Nolan BE, DeRanieri D, Khojah AM. Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy. Curr Treatm Opt Rheumatol 2021;7:39-62. [PMID: 34354904 DOI: 10.1007/s40674-020-00168-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Toplak N, Pimpale Chavan P, Rosina S, Dallos T, Rotem Semo O, Aguiar CL, Khubchandani R, Ravelli A, Patwardhan A. Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series. Front Pediatr 2022;9:810785. [DOI: 10.3389/fped.2021.810785] [Reference Citation Analysis]
2 Khojah A, Liu V, Morgan G, Shore RM, Pachman LM. Changes in total body fat and body mass index among children with juvenile dermatomyositis treated with high-dose glucocorticoids. Pediatr Rheumatol Online J 2021;19:118. [PMID: 34376205 DOI: 10.1186/s12969-021-00622-1] [Reference Citation Analysis]